Compare Avail (AVAIL) vs Enzyme (MLN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Avail vs Enzyme — how do they compare? Avail trades at Rp51.19 (market cap Rp200,8M, Rp8,7M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Avail is the larger of the two by market cap, and Avail's circulating supply is 3,9B AVAIL versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold Avail for 18 Days and Enzyme for 28 Days on average.
| AVAIL | MLN | |
|---|---|---|
Market Cap | Rp200,8M | Rp134,13M |
Volume (24h) | Rp8,7M | Rp104,56M |
Circulating Supply | 3,9B AVAIL | 3,3M MLN |
Typical Hold Time | 18 Days | 28 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Avail is trading at Rp52.169 with a market cap of Rp203.92M, showing a bearish technical signal driven by moving averages. The asset has a short hold time of 18 days, indicating trader impatience. No major protocol updates or ecosystem developments are noted recently. Support is firm at Rp51 and Rp52, while resistance lies at Rp52 and Rp53, creating a tight trading range.
Overall outlook is cautious due to bearish momentum and low liquidity. Key opportunities include potential rebounds from support levels, but risks involve high volatility and limited market depth. Investors should monitor for any network updates or exchange listings that could improve sentiment.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134.13 million and circulating supply of 3.3 million tokens. The asset demonstrates relatively low volatility with a 28-day average hold time, suggesting stable holding patterns among current investors. Trading volumes appear subdued, indicating limited market participation and liquidity depth at current levels.
Overall outlook remains cautious due to thin liquidity and limited ecosystem developments. Key opportunities include potential protocol upgrades and ecosystem expansion, while major risks center around low trading volumes and regulatory uncertainty in the cryptocurrency space. Investors should monitor network activity and exchange listings for catalysts.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Avail
Avail is a blockchain project designed to address the complexities of data availability and interoperability within the decentralized ecosystem. As a modular blockchain base layer, Avail provides a common data availability layer that facilitates seamless interaction between different blockchains. This foundational layer is crucial for next-generation, trust-minimized applications, enabling them to operate efficiently and securely.
Read more on AVAIL →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
